Evidence map›Paper›PMID 42453770›Full record

ArticleExperimental and therapeutic medicine2026

Androgen rapidly activates phosphorylation signaling pathways in Sertoli cells.

Rui Sun, Ye Du, Lian Gao, Zhu Wang, Hui Liang, Ying Zhang, Qiong Deng

Abstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rui SunDepartment of Urology, Affiliated Longhua Hospital, Southern University of Science and Technology, Shenzhen, Guangdong 518109, P.R. China.
Ye DuDepartment of Urology, Affiliated Longhua Hospital, Southern University of Science and Technology, Shenzhen, Guangdong 518109, P.R. China.
Lian GaoDepartment of Urology, Affiliated Longhua Hospital, Southern University of Science and Technology, Shenzhen, Guangdong 518109, P.R. China.
Zhu WangDepartment of Urology, Affiliated Longhua Hospital, Southern University of Science and Technology, Shenzhen, Guangdong 518109, P.R. China.
Hui LiangDepartment of Urology, Affiliated Longhua Hospital, Southern University of Science and Technology, Shenzhen, Guangdong 518109, P.R. China.
Ying ZhangDepartment of Urology, Affiliated Longhua Hospital, Southern University of Science and Technology, Shenzhen, Guangdong 518109, P.R. China.
Qiong DengDepartment of Urology, Affiliated Longhua Hospital, Southern University of Science and Technology, Shenzhen, Guangdong 518109, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Androgen-activated phosphorylation signaling pathways are of critical importance during spermatogenesis. The present study comprehensively analyzed androgen-activated phosphorylation signaling pathways in testicular Sertoli cells. Primary cultured mouse Sertoli cells were treated with testosterone for varying durations. Using tandem mass tag-labeled phosphoproteomics technology combined with Mfuzz clustering and functional enrichment analysis, key phosphorylation signaling pathways were identified. Mass spectrometry revealed 13,015 quantifiable phosphorylation sites, and Mfuzz clustering of expression pattern categorized 330 proteins into 6 clusters. Functional enrichment analysis highlighted key pathways, including Rap1 and MAPK kinases. Inhibitor experiments confirmed that the disruption of phosphorylation signaling impaired the integrity of the blood-testis barrier. Collectively, these findings demonstrated that androgens rapidly activate the protein phosphorylation signaling network in Sertoli cells, regulating critical processes such as blood-testis barrier formation, thereby providing new insights into male fertility and potential therapeutic strategies for spermatogenic disorders.

Indexed as

androgenblood-testis barriercaveolin-1nonclassical pathwaysphosphorylationSertoli cells

Identifiers

PMID42453770
PMCPMC13365864

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.